348 related articles for article (PubMed ID: 19443091)
1. Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants.
Almeida Vde C; Mussi-Pinhata MM; De Souza CB; Kubo CA; Martinez EZ; Carneiro-Sampaio MM; Duarte G
Vaccine; 2009 Jun; 27(29):3856-61. PubMed ID: 19443091
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies.
Quiambao BP; Nohynek HM; Käyhty H; Ollgren JP; Gozum LS; Gepanayao CP; Soriano VC; Makela PH
Vaccine; 2007 May; 25(22):4470-7. PubMed ID: 17442467
[TBL] [Abstract][Full Text] [Related]
3. Mother-infant vaccination with pneumococcal polysaccharide vaccine: persistence of maternal antibodies and responses of infants to vaccination.
Holmlund E; Nohynek H; Quiambao B; Ollgren J; Käyhty H
Vaccine; 2011 Jun; 29(28):4565-75. PubMed ID: 21550374
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
Abzug MJ; Pelton SI; Song LY; Fenton T; Levin MJ; Nachman SA; Borkowsky W; Rosenblatt HM; Marcinak JF; Dieudonne A; Abrams EJ; Pathak I;
Pediatr Infect Dis J; 2006 Oct; 25(10):920-9. PubMed ID: 17006288
[TBL] [Abstract][Full Text] [Related]
5. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
[TBL] [Abstract][Full Text] [Related]
6. Pneumococcal nasopharyngeal carriage among infants born to human immunodeficiency virus-infected mothers immunized with pneumococcal polysaccharide vaccine during gestation.
Almeida Vde C; Negrini BV; Cervi MC; Isaac Mde L; Mussi-Pinhata MM
Pediatr Infect Dis J; 2011 Jun; 30(6):466-70. PubMed ID: 21200361
[TBL] [Abstract][Full Text] [Related]
7. [Pneumococcal vaccination of the pregnant woman in Africa and passive immunity of the child. Immunologic control by the ELISA method].
Vincent-Ballereau F; Fortier B; Armand J; Lafaix C
Pathol Biol (Paris); 1985 Sep; 33(7):764-7. PubMed ID: 3909074
[TBL] [Abstract][Full Text] [Related]
8. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya.
Cumberland P; Shulman CE; Maple PA; Bulmer JN; Dorman EK; Kawuondo K; Marsh K; Cutts FT
J Infect Dis; 2007 Aug; 196(4):550-7. PubMed ID: 17624840
[TBL] [Abstract][Full Text] [Related]
9. Ineffectiveness for infants of immunization of mothers with pneumococcal capsular polysaccharide vaccine during pregnancy.
Lopes CR; Berezin EN; Ching TH; Canuto Jde S; Costa VO; Klering EM
Braz J Infect Dis; 2009 Apr; 13(2):104-6. PubMed ID: 20140352
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.
de Roux A; Schmöle-Thoma B; Siber GR; Hackell JG; Kuhnke A; Ahlers N; Baker SA; Razmpour A; Emini EA; Fernsten PD; Gruber WC; Lockhart S; Burkhardt O; Welte T; Lode HM
Clin Infect Dis; 2008 Apr; 46(7):1015-23. PubMed ID: 18444818
[TBL] [Abstract][Full Text] [Related]
11. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.
Baker CJ; Rench MA; Edwards MS; Carpenter RJ; Hays BM; Kasper DL
N Engl J Med; 1988 Nov; 319(18):1180-5. PubMed ID: 3050524
[TBL] [Abstract][Full Text] [Related]
12. Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children.
Kamchaisatian W; Wanwatsuntikul W; Sleasman JW; Tangsinmankong N
J Allergy Clin Immunol; 2006 Dec; 118(6):1336-41. PubMed ID: 17157665
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and reactogenicity of pneumococcal polysaccharide and conjugate vaccines in alaska native adults 55-70 years of age.
Miernyk KM; Butler JC; Bulkow LR; Singleton RJ; Hennessy TW; Dentinger CM; Peters HV; Knutsen B; Hickel J; Parkinson AJ
Clin Infect Dis; 2009 Jul; 49(2):241-8. PubMed ID: 19522655
[TBL] [Abstract][Full Text] [Related]
15. The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.
Bermal N; Szenborn L; Chrobot A; Alberto E; Lommel P; Gatchalian S; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S89-96. PubMed ID: 19325451
[TBL] [Abstract][Full Text] [Related]
16. Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults.
Scott DA; Komjathy SF; Hu BT; Baker S; Supan LA; Monahan CA; Gruber W; Siber GR; Lockhart SP
Vaccine; 2007 Aug; 25(33):6164-6. PubMed ID: 17629361
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity for 16 serotypes of a unique schedule of pneumococcal vaccines in a high-risk population.
Leach AJ; Morris PS; Mackenzie G; McDonnell J; Balloch A; Carapetis J; Tang M
Vaccine; 2008 Jul; 26(31):3885-91. PubMed ID: 18562052
[TBL] [Abstract][Full Text] [Related]
18. Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults.
Lesprit P; Pédrono G; Molina JM; Goujard C; Girard PM; Sarrazin N; Katlama C; Yéni P; Morineau P; Delfraissy JF; Chêne G; Lévy Y;
AIDS; 2007 Nov; 21(18):2425-34. PubMed ID: 18025879
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of pneumococcal conjugate polysaccharide and free polysaccharide vaccines alone or combined in HIV-infected adults in Brazil.
Ho YL; Brandão AP; de Cunto Brandileone MC; Lopes MH
Vaccine; 2013 Aug; 31(37):4047-53. PubMed ID: 23684823
[TBL] [Abstract][Full Text] [Related]
20. Improving the immunogenicity of pneumococcal conjugate vaccine in HIV-infected adults with a toll-like receptor 9 agonist adjuvant: a randomized, controlled trial.
Søgaard OS; Lohse N; Harboe ZB; Offersen R; Bukh AR; Davis HL; Schønheyder HC; Østergaard L
Clin Infect Dis; 2010 Jul; 51(1):42-50. PubMed ID: 20504165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
